Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy

Esther Rodríguez‐Gallego(Institut de Recerca Biomèdica Catalunya Sud), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Raúl Beltrán‐Debón(Institut de Recerca Biomèdica Catalunya Sud), Verònica Alba, Félix Gutiérrez(Universitat de Miguel Hernández d'Elx), Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), Sara Ferrando‐Martínez(National Institutes of Health), Manuel Leal(Apple (Israel)), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Josep Gómez(Hospital Universitari Joan XXIII de Tarragona), Peré Domingo(Hospital de Sant Pau), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Miguel López-Dupla, Montserrat Vargas(Hospital Universitari Joan XXIII de Tarragona), Sergi Veloso, Alfonso J. Castellano(Institut de Recerca Biomèdica Catalunya Sud), Joaquim Peraire(Instituto de Salud Carlos III), Ezequiel Ruíz-Mateos(Apple (Israel))
Atherosclerosis
April 9, 2018
10.1016/j.atherosclerosis.2018.04.008
Cited by 19

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332
Ultraviolet vision in lizards
|Nature|1993|257